Compare TNYA & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNYA | ALPS |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.6M | 158.8M |
| IPO Year | 2021 | N/A |
| Metric | TNYA | ALPS |
|---|---|---|
| Price | $0.73 | $0.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.25 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 57.1K |
| Earning Date | 03-09-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,741,201.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 26.69 |
| 52 Week Low | $0.36 | $0.56 |
| 52 Week High | $2.35 | $15.00 |
| Indicator | TNYA | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 36.85 | N/A |
| Support Level | $0.70 | N/A |
| Resistance Level | $0.78 | N/A |
| Average True Range (ATR) | 0.05 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 32.66 | 0.00 |
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.